Treatment resistant depression Market Insight, Epidemiology And Market Forecast 2032

 



Treatment-resistant depression (TRD) typically refers to inadequate response to at least one antidepressant trial of adequate doses and duration. Treatment-resistant depression is a relatively common occurrence in clinical practice, with up to 50–60% of the patients not achieving adequate response following antidepressant treatment.

Treatment-Resistant Depression Epidemiology Segmentation in the 7MM 

  • Total Diagnosed Prevalent Cases Treatment-Resistant Depression
  • Age-Specific Cases of Treatment-Resistant Depression
  • Gender-specific Cases of Treatment-Resistant Depression

Treatment-Resistant Depression Epidemiological Insights Observed in the 7MM (2021)

  • The total prevalent cases of Treatment-Resistant Depression in the 7MM were estimated to be 5.8 million.
  • The total prevalent cases of Treatment-Resistant Depression in the US were estimated to be 3.9 million.
  • The total prevalent cases of Treatment-Resistant Depression in Germany was found to be 558k and in Italy, they were found to be 127k in the year 2021.

Treatment-Resistant Depression Market Insight

The market size of Treatment-Resistant Depression in the 7MM was found to be USD 2,450 million in 2021. 

Treatment-Resistant Depression Emerging Therapies

The emerging drugs in the Treatment-Resistant Depression market are

  • AXS-05
  • VRAYLAR
  • Esketamine DPI
  • REL-1017
  • COMP360
  • MIJ821
  • Liafensine
  • MK-1942
  • NV5138
  • TS161
  • AV-101, and many others

Treatment-Resistant Depression Companies

The key players working in the Treatment-Resistant Depression market are

  • Axsome Therapeutics
  • AbbVie
  • Celon Pharma
  • Relmada Therapeutics
  • COMPASS Pathways
  • Novartis
  • Denovo Biopharma
  • Merck Sharp and Dohme Corp
  • Navitor Pharmaceuticals, Inc.
  • Supernus Pharmaceuticals, Inc.
  • Taisho Pharmaceutical Co., Ltd
  • VistaGen Therapeutics, and several others

Related Topics

Treatment resistant depression

Treatment resistant depression Market

Treatment resistant depression infographic

Treatment resistant depression Market Infographic


Comments

Post a Comment

Popular posts from this blog

Phosphoglucomutase 1 Deficiency Market is expected to show positive growth, during the forecast period of 2019 to 2032, DelveInsight

Image
  DelveInsight's " Phosphoglucomutase 1 Deficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Phosphoglucomutase 1 Deficiency, historical and forecasted epidemiology as well as the Phosphoglucomutase 1 Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Phosphoglucomutase 1 Deficiency market report provides current treatment practices, emerging drugs, Phosphoglucomutase 1 Deficiency market share of the individual therapies, current and forecasted Phosphoglucomutase 1 Deficiency market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Phosphoglucomutase 1 Deficiency treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Phosphoglucomutase 1 Deficiency market. Do you want to know its market sh
Read more

From Lab to Market: Pharma Industry Research Reports

Image
  Lactose Intolerance Market Lactose intolerance affects a significant portion of the global population, with varying degrees of severity among different ethnic groups. The condition can cause a range of uncomfortable symptoms, such as bloating, gas, abdominal pain, diarrhea, and nausea, occurring shortly after consuming lactose-containing foods. The lactose intolerance market refers to the sector of the healthcare industry that deals with products and services aimed at addressing and managing lactose intolerance, a condition in which the body is unable to properly digest lactose, a sugar found in milk and dairy products. This intolerance occurs due to a deficiency of lactase, the enzyme responsible for breaking down lactose in the digestive system. Visit our website-  https://www.delveinsight.com/report-store/lactose-intolerance-market Meningococcal Meningitis Market The meningococcal meningitis market has seen significant growth in recent years, primarily due to the increasing awaren
Read more

Pediatric Central Nervous System Tumors Market is expected to show positive growth, during the study period of 2019 to 2032, DelveInsight

Image
    About Pediatric Central Nervous System Tumors Disease Non-malignant and malignant tumours of the brain and spinal cord are both classified as central nervous system (CNS) cancers. Primary malignant CNS tumours are the most frequent paediatric solid organ tumours and the second most common children malignancies after hematologic malignancies. DelveInsight's " Pediatric Central Nervous System Tumors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pediatric Central Nervous System Tumors, historical and forecasted epidemiology as well as the Pediatric Central Nervous System Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Pediatric Central Nervous System Tumors market report provides current treatment practices, emerging drugs, Pediatric Central Nervous System Tumors market share of the individual therapies, current and forecasted Pediatric Central
Read more